More than 180 million people worldwide suffer from diabetes, including 23.6 million Americans. Today’s leading treatments, developed 25 years ago, are based on incomplete knowledge and present significant opportunities for improvement. The time is ripe for a therapeutic breakthrough.

Metabolic Solutions is developing innovative therapeutics using a novel target identified by the company to treat diabetes and related symptoms of metabolic syndrome. This new approach seeks to improve the efficacy of treatment by freeing patients from the adverse side effects of current treatments, including edema and weight gain.

Our scientific strategy is built on a historical understanding of insulin sensitizers and our unique insight into the mechanism of insulin-sensitizing pharmacology. The result will be a new generation of superior, safer drug therapies for this large and growing market.